期刊论文详细信息
Cancers
Complications from Stereotactic Body Radiotherapy for Lung Cancer
Kylie H. Kang3  Christian C. Okoye1  Ravi B. Patel1  Shankar Siva2  Tithi Biswas1  Rodney J. Ellis1  Min Yao1  Mitchell Machtay1  Simon S. Lo1 
[1] Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA; E-Mails:;Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; E-Mail:;School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; E-Mail:
关键词: stereotactic body radiation therapy (SBRT);    stereotactic ablative radiotherapy (SABR);    non-small cell lung cancer (NSCLC);    toxicity;    complications;   
DOI  :  10.3390/cancers7020820
来源: mdpi
PDF
【 摘 要 】

Stereotactic body radiotherapy (SBRT) has become a standard treatment option for early stage, node negative non-small cell lung cancer (NSCLC) in patients who are either medically inoperable or refuse surgical resection. SBRT has high local control rates and a favorable toxicity profile relative to other surgical and non-surgical approaches. Given the excellent tumor control rates and increasing utilization of SBRT, recent efforts have focused on limiting toxicity while expanding treatment to increasingly complex patients. We review toxicities from SBRT for lung cancer, including central airway, esophageal, vascular (e.g., aorta), lung parenchyma (e.g., radiation pneumonitis), and chest wall toxicities, as well as radiation-induced neuropathies (e.g., brachial plexus, vagus nerve and recurrent laryngeal nerve). We summarize patient-related, tumor-related, dosimetric characteristics of these toxicities, review published dose constraints, and propose strategies to reduce such complications.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.

【 预 览 】
附件列表
Files Size Format View
RO202003190010782ZK.pdf 600KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:6次